Oxidative stress in stable cystic fibrosis patients: Do we need higher antioxidant plasma levels?

Journal of Cystic Fibrosis

Volumn 12, Issue 1, 2013, Pages 35-41

  Lezo, Antonela ^a   Biasi, Fiorella ^a   Massarenti, Paola ^b   Calabrese, Roberto ^a   Poli, Giuseppe ^a   Santini, Bruna ^a   Bignamini, Elisabetta ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b SG Battista Hospital   (Italy)

^c Sant'Anna OIRM Hospital   (Italy)

Author keywords

Antioxidant vitamins; Lipid oxidation; Nutrition; Pancreatic insufficiency

Indexed keywords

4 HYDROXYNONENAL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; MALONALDEHYDE; RETINOL;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CYSTIC FIBROSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PANCREAS INSUFFICIENCY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ALDEHYDES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CYSTEINE PROTEINASE INHIBITORS; CYSTIC FIBROSIS; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; FLUOROMETRY; HUMANS; INFANT; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; REFERENCE VALUES;

EID: 84870760826     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.06.002     Document Type: Article

References (30)

1. Van der Vliet A., Eiserich J.P., Marelich G.P., Halliwell B., Cross C.E. Oxidative stress in cystic fibrosis: does it occur and does it matter?. Adv Pharmacol 1997, 38:491-513.
2. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., Collins C.E., Garg M.L. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001, 20:157-165. [Suppl.].
3. Back E.I., Frindt C., Nohr D., et al. Antioxidant deficiency in cystic fibrosis: when is the right time to take action?. Am J Clin Nutr 2004, 80:374-384.
4. Brown R.K., Kelly F.J. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1996, 36:487-493.
5. Lagrange-Puget M., Durieu I., Ecochard R., et al. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr Pulmonol 2004, 38:43-49.
6. Hakim F., Kerem E., Rivlin J., et al. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2007, 45:347-353.
7. Huang S.H., Schall J.I., Zemel B.S., Stallings V.A. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr 2006, 148:556-559.
8. Lancellotti L., D'Orazio C., Mastella G., Mazzi G., Lippi U. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr 1996, 155(4):281-285.
9. Sinaasappel M., Stern M., Littlewood J., et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002, 1:51-75.
10. Borowitz D., Baker R.D., Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002, 35:246-259.
11. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52:601-623.
12. Breusing N., Grune T., Andrisic L., et al. An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples. Free Radic Res 2010, 44(10):1203-1215.
13. Negre-Salvayre A., Auge N., Ayala V., et al. Pathological aspects of lipid peroxidation. Free Radic Res 2010, 44(10):1125-1171.
14. Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., Barnes P.J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999, 160:216-220.
15. Schaur R.J. Basic aspects of biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 2003, 24:149-159.
16. Corradi M., Pignatti P., Manini P., et al. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J 2004, 24(6):1011-1017.
17. Bartoli M.L., Novelli F., Costa F., Malagrinò L., et al. Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm 2011, 2011:891752. [Epub 2011 Jun 16].
18. Sadowska-Woda I., Rachel M., Pazdan J., Bieszczad-Bedrejczuk E., Pawliszak K. Nutritional supplement attenuates selected oxidative stress markers in pediatric patients with cystic fibrosis. Nutr Res 2011, 31(7):509-518.
19. Lepage G., Champagne J., Ronco N., et al. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1996, 64(1):87-93.
20. Poli G., Schaur R.J., Siems W.G., Leonarduzzi G. 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 2008, 28(4):569-631.
21. Harapanalli R.S., Howell R.W., Rao D.V. Testicular and plasma ascorbic acid levels in mice following dietary intake: a high-performance liquid chromatographic analysis. J Chromatogr 1993, 614:233-243.
22. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
23. Biesalski H.K., Böhles H., Esterbauer H., et al. Antioxidant vitamins in prevention. Clin Nutr 1997, 16:151-155.
24. Livelli di Assunzione giornalieri Raccomandati di Nutrienti per la popolazione italiana (L.A.R.N.), Società Italiana di Nutrizione Umana, ed. Rome; 1996.
25. NHANES 1999-2000 Data Files. National Health and Nutrition Survey Data 2004, Public Health Survey, Centre for Disease Control and Prevention, Hyattsville, Maryland.
26. Winklhofer-Roob B.M., Ellemunter H., Frühwirth M., et al. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation. Am J Clin Nutr 1997, 65:1858-1866.
27. Cantin A.M. Potential for antioxidant therapy of cystic fibrosis. Curr Opin Pulm Med 2004, 10:531-536.
28. Fischer H., Schwarzer C., Illek B. Vitamin C controls the CFTR chloride channel. Proc Natl Acad Sci 2004, 10:3691-3696.
29. Maqbool A., Graham-Maar R.C., Schall J.I., Zemel B.S., Stallings V.A. Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis. J Cyst Fibros 2008, 7:137-141.
30. Bo S., Ciccone G., Durazzo M., et al. Efficacy of antioxidant treatment in reducing resistin serum levels: a randomized study. PLoS Clin Trials 2007, 2(5):e17.